Literature DB >> 8361179

Pulmonary vascular disease and operative indications in complete atrioventricular canal defect in early infancy.

S Yamaki1, H Yasui, H Kado, K Yonenaga, Y Nakamura, T Kikuchi, H Ajiki, M Tsunemoto, H Mohri.   

Abstract

Pulmonary vascular disease was morphometrically analyzed in 67 patients (mean age, 19 months) with isolated complete atrioventricular canal defect. Complete obstruction of the small pulmonary arterial lumen resulting from acute fibrous proliferation and atrophy of the peripheral arterial media, which were considered absolute operative contraindications, were characteristic in six patients with Down's syndrome. Morphometric analysis of medial thickness revealed that thinning of the media of the small pulmonary arteries is generally observed at around 6 months of age in patients with complete atrioventricular canal defect and that the media in patients who have complete atrioventricular canal defect and Down's syndrome was thinner than that in such patients without Down's syndrome. These results suggest that thinning of the media as a result of two factors--Down's syndrome and aging--facilitates the rapid occurrence of fibrous intimal proliferation. Therefore intracardiac repair is desirable within 6 months of life, before medial thinning, in patients with complete atrioventricular canal defect and Down's syndrome. Excluding patients with absolute operative contraindications, the scores of the index of pulmonary vascular disease in operative survivors were below 2.0 and death occurred when scores were more than 2.2. The pulmonary vascular resistances measured in room air and by the oxygen inhalation and tolazoline tests in patients with operative contraindications were more than 7.3, 3.8, and 6.6 units.m2, respectively. We thus conclude that lung biopsy should be undertaken for patients in whom pulmonary vascular resistance is beyond these values to determine the appropriateness of surgical intervention.

Entities:  

Mesh:

Year:  1993        PMID: 8361179

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  11 in total

1.  Down syndrome patients with pulmonary hypertension have elevated plasma levels of asymmetric dimethylarginine.

Authors:  Clifford L Cua; Lynette K Rogers; Louis G Chicoine; Molly Augustine; Yi Jin; Patricia L Nash; Leif D Nelin
Journal:  Eur J Pediatr       Date:  2010-12-01       Impact factor: 3.183

2.  Congenital heart surgery outcomes in Down syndrome: analysis of a national clinical database.

Authors:  James C Fudge; Shuang Li; James Jaggers; Sean M O'Brien; Eric D Peterson; Jeffrey P Jacobs; Karl F Welke; Marshall L Jacobs; Jennifer S Li; Sara K Pasquali
Journal:  Pediatrics       Date:  2010-07-12       Impact factor: 7.124

3.  The effect of changing attitudes to Down's syndrome in the management of complete atrioventricular septal defects.

Authors:  K Amark; J Sunnegårdh
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

4.  [Repair of complete atrioventricular septal defect with severe pulmonary hypertension--effect of re-pulmonary artery banding and analysis of lung biopsy: a case report].

Authors:  M Yamasaki; S Kawasaki; H Satoh; K Minami; Y Hosoda; S Yamaki
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1998-06

5.  Single ventricle repair in children with Down's syndrome.

Authors:  Naoki Wada; Yukihiro Takahashi; Makoto Ando; In-Sam Park; Takashi Sasaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-03-14

6.  Plasma endothelin-1 and nitrate levels in Down's syndrome with complete atrioventricular septal defect-associated pulmonary hypertension: a comparison with non-Down's syndrome children.

Authors:  Metin Sungur; Burhan Ocal; Deniz Oğuz; Selmin Karademir; Cemşit Karakurt; Filiz Senocak
Journal:  Eur J Pediatr       Date:  2008-08-06       Impact factor: 3.183

7.  Complete versus partial atrioventricular canal: equal risks of repair in the modern era.

Authors:  Jeffrey T Cope; Gregory D Fraser; Peter C Kouretas; Irving L Kron
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

8.  Pulmonary vascular disease associated with pulmonary hypertension in 445 patients: diagnosis from lung biopsy and autopsy.

Authors:  Shigeo Yamaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-09-26

9.  Effect of bosentan on exercise capacity and clinical worsening in patients with dual down and eisenmenger syndrome.

Authors:  Giorgio Serino; Marco Guazzi; Angelo Micheletti; Carlo Lombardi; Rossella Danesi; Diana Negura; Mario Carminati; Massimo Chessa
Journal:  Clin Med Insights Cardiol       Date:  2013-02-06

10.  Long-term results of treatment with bosentan in adult Eisenmenger's syndrome patients with Down's syndrome related to congenital heart disease.

Authors:  Roberto Crepaz; Cristina Romeo; Donato Montanaro; Stefano De Santis
Journal:  BMC Cardiovasc Disord       Date:  2013-09-18       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.